The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 What Athletes Need to Know About Legality, Safety and Efficacy Training & Conditioning 2025 Breakthroughs in Regenerative Peptides: Spotlight on BPC 157 Mechanisms by Anyniat Karoka Medium August 11, 2025: The FDA voices concern about sites that supply compounding ingredients Partnership for Safe Medicines Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law